These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14522016)

  • 21. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
    Fleuridor R; Lees A; Pirofski L
    J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.
    Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G
    Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isotype can affect the fine specificity of an antibody for a polysaccharide antigen.
    McLean GR; Torres M; Elguezabal N; Nakouzi A; Casadevall A
    J Immunol; 2002 Aug; 169(3):1379-86. PubMed ID: 12133962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Rodríguez Sánchez H; Pupo Antúnez M; Ilnait MT; Otero A; Martínez Machín G
    Rev Cubana Med Trop; 2005; 57(2):162-4. PubMed ID: 17966590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.
    Deshaw M; Pirofski LA
    Clin Exp Immunol; 1995 Mar; 99(3):425-32. PubMed ID: 7882565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype.
    Torres M; May R; Scharff MD; Casadevall A
    J Immunol; 2005 Feb; 174(4):2132-42. PubMed ID: 15699144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures.
    Oscarson S; Alpe M; Svahnberg P; Nakouzi A; Casadevall A
    Vaccine; 2005 Jun; 23(30):3961-72. PubMed ID: 15917118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
    Martinez LR; Moussai D; Casadevall A
    Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure.
    Janda A; Casadevall A
    Mol Immunol; 2010 Apr; 47(7-8):1421-5. PubMed ID: 20299100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.
    Nakouzi A; Zhang T; Oscarson S; Casadevall A
    Vaccine; 2009 Jun; 27(27):3513-8. PubMed ID: 19464529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
    Duro RM; Netski D; Thorkildson P; Kozel TR
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):252-8. PubMed ID: 12626451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
    Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
    Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide.
    Lendvai N; Casadevall A; Liang Z; Goldman DL; Mukherjee J; Zuckier L
    J Infect Dis; 1998 Jun; 177(6):1647-59. PubMed ID: 9607845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan.
    Houpt DC; Pfrommer GS; Young BJ; Larson TA; Kozel TR
    Infect Immun; 1994 Jul; 62(7):2857-64. PubMed ID: 8005676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis.
    Fleuridor R; Zhong Z; Pirofski L
    J Infect Dis; 1998 Oct; 178(4):1213-6. PubMed ID: 9806064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.
    Valadon P; Nussbaum G; Boyd LF; Margulies DH; Scharff MD
    J Mol Biol; 1996 Aug; 261(1):11-22. PubMed ID: 8760499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
    Ichiyoshi Y; Casali P
    J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.
    Goldman DL; Lee SC; Casadevall A
    Infect Immun; 1995 Sep; 63(9):3448-53. PubMed ID: 7642276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
    Parra C; González JM; Castañeda E; Fiorentino S
    Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.
    Bowen A; Wear MP; Cordero RJ; Oscarson S; Casadevall A
    J Biol Chem; 2017 Jan; 292(2):417-434. PubMed ID: 27872188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.